Search

everythinglearnresearchcommunity

for

Search:↓

Frontal fibrosing alopecia is linked to increased immune system activity and reduced stem cells, suggesting early treatment targeting this pathway might prevent hair follicle damage.

People with alopecia areata are more likely to have other immune-related conditions.

Alopecia Areata might be linked to Crohn's disease.

Targeted cytokine treatments may help with alopecia areata, but more research is needed.

Ustekinumab helped three kids with alopecia areata regrow hair.

The current understanding of frontal fibrosing alopecia involves immune, genetic, hormonal factors, and possibly environmental triggers, but more research is needed for effective treatments.

IL-17 inhibitors for psoriasis may cause unexpected hair loss.

Hair growth phase in mice weakens certain immune responses.

Leptin affects skin and hair health and may worsen some skin conditions, but more research is needed to understand its full impact.

Dupilumab treatment reduces Th2-related markers and helps hair growth in alopecia areata, showing Th2's role in the condition.

Reduced SIRT1 in hair cells may cause alopecia areata by triggering immune responses.

Dupilumab may worsen Alopecia Areata in some males but improve it in some females, suggesting personalized treatment is needed.

The document did not conclude on apremilast's effectiveness for severe alopecia areata.

A small 3D skin model helps study how immune cells move in the skin.

Janus kinase inhibitors show promise in treating alopecia areata but need more safety research.

Recent findings suggest that genetic factors, immune system issues, and skin cell defects might contribute to the development of hidradenitis suppurativa.

Oral JAK inhibitors improved alopecia areata by modulating immune responses and boosting hair growth.

New treatments for seborrheic dermatitis show promise for difficult cases.

Alopecia areata is a hair loss disease caused by complex immune reactions, and new targeted treatments show promise.

People with alopecia areata may also have allergic rhinitis and should be checked for respiratory allergies.

RXRa is crucial for Th2 immune cell development and may link nutrition to immune health.

Alopecia areata involves complex immune dysregulation, mainly driven by Th1 activity, suggesting broader treatment strategies.

Dupilumab users have a higher risk of developing alopecia areata.

Dupilumab can both improve and worsen alopecia areata, with higher IgE levels linked to better outcomes.

Fzd2 is important for skin and hair development through various signaling ways.

Alopecia areata involves complex immune activity, mainly Th1, with potential benefits from broader immune treatments.

Brepocitinib improves cicatricial alopecia and reduces key immune markers.

Allergies, especially dust mite allergy, may worsen alopecia areata, and desensitization could help reduce its severity.

Scalp psoriasis is a chronic condition that can be managed with treatments like corticosteroids and salicylic acid.

Alopecia areata involves immune system issues and specific cell types that disrupt hair growth, leading to hair loss.